drugset / Trial / NCT00035230

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

NCT00035230

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to evaluate the safety and efficacy of topiramate compared with placebo in the treatment of acute manic or mixed episodes in patients with Bipolar I Disorder.

Timeline

Start
2001-07
Primary completion
Completion
2002-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 400 mg Oral

Indications